Home/Filings/4/0000950170-25-099251
4//SEC Filing

Cumbo Alexander 4

Accession 0000950170-25-099251

CIK 0001840574other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 5:15 PM ET

Size

8.7 KB

Accession

0000950170-25-099251

Insider Transaction Report

Form 4
Period: 2025-07-25
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-07-2542,2000 total
    Exercise: $5.73Common Stock (42,200 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-07-25136,1390 total
    Exercise: $5.02Common Stock (136,139 underlying)
Footnotes (2)
  • [F1]Pursuant to the terms of an Agreement and Plan of Merger, dated as of June 16, 2025, by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation, at the effective time of the Merger (the "Effective Time"), each outstanding stock option of Issuer having an exercise price less than $10.50 per share in cash, without interest and less any applicable tax withholding (the "Cash Consideration") (each such option, a "Cash-Out Stock Option") that is outstanding immediately prior to the Effective Time, whether or not vested, was automatically cancelled, by virtue of the Merger and without any action on the part of any holder of any Cash-Out Stock Option, and each holder of such Cash-Out Stock Option received (without interest) (i) an amount in cash (less any applicable tax withholdings) equal to the product of (a) the excess, if any, of the Cash Consideration over the
  • [F2](continued from footnote 1) applicable exercise price per share underlying such Cash-Out Stock Option multiplied by (b) the total number of shares of the Issuer's Common Stock subject to such Cash-Out Stock Option and (ii) one non-tradeable contingent value right for each share subject to such Cash-Out Stock Option (without regard to vesting).

Documents

1 file

Issuer

Verve Therapeutics, Inc.

CIK 0001840574

Entity typeother

Related Parties

1
  • filerCIK 0001685994

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 5:15 PM ET
Size
8.7 KB